Predictive Value of Combined Positive Score and Tumor Proportion Score for Immunotherapy Response in Advanced NSCLC.

导出 LinkOut

翻译打印收藏纠错

作者： Ezgi B,Ulas ^[1] ; Sayed M S,Hashemi ^[1] ; Ilias,Houda ^[1] ; Adem,Kaynak ^[1] ; Joris D,Veltman ^[1] ; Marieke F,Fransen ^[1] ; Teodora,Radonic ^[2] ; Idris,Bahce ^[1]

作者单位： Department of Pulmonary Medicine, Amsterdam University Medical Centers, Location VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands. ^[1] Department of Pathology, Amsterdam University Medical Centers, Location VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands. ^[2]

关键词 Combined positive score Immunotherapy Non–small cell lung cancer PD-L1 Predictive biomarker

DOI 10.1016/j.jtocrr.2023.100532

PMID 37681219

发布时间 2023-09-09

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

JTO clinical and research reports

2023年4卷9期

100532页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Predictive Value of Combined Positive Score and Tumor Proportion Score for Immunotherapy Response in Advanced NSCLC.

JTO clinical and research reports

相似文献

JTO clinical and research reports

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Predictive Value of Combined Positive Score and Tumor Proportion Score for Immunotherapy Response in Advanced NSCLC.

JTO clinical and research reports

相似文献

JTO clinical and research reports

相关期刊

检索历史清除